These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30343433)

  • 1. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage.
    Pietroboni AM; Colombi A; Carandini T; Sacchi L; Fenoglio C; Marotta G; Arighi A; De Riz MA; Fumagalli GG; Castellani M; Bozzali M; Scarpini E; Galimberti D
    Alzheimers Res Ther; 2022 Feb; 14(1):33. PubMed ID: 35151361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
    Matías-Guiu JA; Cabrera-Martín MN; Matías-Guiu J; Oreja-Guevara C; Riola-Parada C; Moreno-Ramos T; Arrazola J; Carreras JL
    BMC Neurol; 2015 Nov; 15():243. PubMed ID: 26607782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
    Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D
    Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of
    Zeydan B; Schwarz CG; Przybelski SA; Lesnick TG; Kremers WK; Senjem ML; Kantarci OH; Min PH; Kemp BJ; Jack CR; Kantarci K; Lowe VJ
    J Nucl Med; 2022 Aug; 63(8):1239-1244. PubMed ID: 34916245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.
    Pietroboni AM; Scarioni M; Carandini T; Basilico P; Cadioli M; Giulietti G; Arighi A; Caprioli M; Serra L; Sina C; Fenoglio C; Ghezzi L; Fumagalli GG; De Riz MA; Calvi A; Triulzi F; Bozzali M; Scarpini E; Galimberti D
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):352-357. PubMed ID: 29054920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET in pseudotumoral multiple sclerosis.
    Matías-Guiu JA; Cabrera-Martín MN; Cortés-Martínez A; Pytel V; Moreno-Ramos T; Oreja-Guevara C; Carreras JL; Matías-Guiu J
    Mult Scler Relat Disord; 2017 Jul; 15():15-17. PubMed ID: 28641766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF β-amyloid predicts prognosis in patients with multiple sclerosis.
    Pietroboni AM; Caprioli M; Carandini T; Scarioni M; Ghezzi L; Arighi A; Cioffi S; Cinnante C; Fenoglio C; Oldoni E; De Riz MA; Basilico P; Fumagalli GG; Colombi A; Giulietti G; Serra L; Triulzi F; Bozzali M; Scarpini E; Galimberti D
    Mult Scler; 2019 Aug; 25(9):1223-1231. PubMed ID: 30084711
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Moscoso A; Silva-Rodríguez J; Aldrey JM; Cortés J; Pías-Peleteiro JM; Ruibal Á; Aguiar P;
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1242-1253. PubMed ID: 34581847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W; Zhang Y; Mu K; Pan C; Gauthier SA; Zhu W; Wang Y
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
    Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
    Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
    J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.
    Zeydan B; Lowe VJ; Schwarz CG; Przybelski SA; Tosakulwong N; Zuk SM; Senjem ML; Gunter JL; Roberts RO; Mielke MM; Benarroch EE; Rodriguez M; Machulda MM; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Kantarci K; Kantarci OH
    Mult Scler; 2018 May; 24(6):739-749. PubMed ID: 28474977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
    Bural G; Torigian D; Basu S; Houseni M; Zhuge Y; Rubello D; Udupa J; Alavi A
    Nucl Med Commun; 2015 Dec; 36(12):1249-52. PubMed ID: 26426967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS.
    Pardini M; Gualco L; Bommarito G; Roccatagliata L; Schiavi S; Solaro C; Mancardi G; Uccelli A; Capello E; Inglese M
    Mult Scler Relat Disord; 2019 Jun; 31():93-96. PubMed ID: 30953954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.
    Singhal T; OʼConnor K; Dubey S; Belanger AP; Hurwitz S; Chu R; Tauhid S; Kijewski MF; DiCarli MF; Weiner HL; Bakshi R
    Clin Nucl Med; 2018 Sep; 43(9):e289-e295. PubMed ID: 30004939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
    Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
    J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
    Moccia M; Quarantelli M; Lanzillo R; Cocozza S; Carotenuto A; Carotenuto B; Alfano B; Prinster A; Triassi M; Nardone A; Palladino R; Brunetti A; Brescia Morra V
    Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.